3,351
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Not as “D”eadly as once thought – the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma

, , , , , , & show all
Article: 2161215 | Received 03 Oct 2022, Accepted 18 Dec 2022, Published online: 06 Jan 2023

References

  • Rehn M, Weaver A, Brohi K, et al. Effect of prehospital Red blood cell transfusion on mortality and time of death in civilian Trauma patients. Shock. 2019;51:284–288. doi:10.1097/SHK.0000000000001166.
  • Shackelford SA, Del Junco DJ, Powell-Dunford N, et al. Association of Prehospital blood product transfusion during medical evacuation of combat casualties in Afghanistan with acute and 30-Day survival. JAMA. 2017;318:1581–1591. doi:10.1001/jama.2017.15097.
  • Sperry JL, Guyette FX, Adams PW. Prehospital plasma during air medical transport in Trauma patients. N Engl J Med. 2018;379:1783. doi:10.1056/NEJMoa1802345.
  • Crombie N, Doughty HA, Bishop JRB, et al. Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Haematol. 2022;9:e250–e61. doi:10.1016/S2352-3026(22)00040-0.
  • Yazer MH, Spinella PC, Anto V, et al. Survey of group A plasma and low-titer group O whole blood use in trauma resuscitation at adult civilian level 1 trauma centers in the US. Transfusion. 2021;61:1757–1763. doi:10.1111/trf.16394.
  • Dishong D, Cap AP, Holcomb JB, et al. The rebirth of the cool: a narrative review of the clinical outcomes of cold stored low titer group O whole blood recipients compared to conventional component recipients in trauma. Hematology. 2021;26:601–611. doi:10.1080/16078454.2021.1967257.
  • Brill JB, Tang B, Hatton G, et al. Impact of incorporating whole blood into hemorrhagic shock resuscitation: analysis of 1,377 consecutive trauma patients receiving emergency-release uncrossmatched blood products. J Am Coll Surg. 2022;234:408–418. doi:10.1097/XCS.0000000000000086.
  • Siletz AE, Blair KJ, Cooper RJ, et al. A pilot study of stored low titer group O whole blood + component therapy versus component therapy only for civilian trauma patients. J Trauma Acute Care Surg. 2021;91:655–662. doi:10.1097/TA.0000000000003334.
  • Braverman MA, Smith A, Pokorny D, et al. Prehospital whole blood reduces early mortality in patients with hemorrhagic shock. Transfusion. 2021;61(Suppl 1):S15–S21.
  • Gunson HH, Stratton F, Cooper DG, et al. Primary immunization of Rh-negative volunteers. Br Med J. 1970;1:593–595. doi:10.1136/bmj.1.5696.593.
  • Urbaniak SJ, Robertson AE. A successful program of immunizing Rh-negative Male volunteers for anti-D production using frozen/thawed blood. Transfusion. 1981;21:64–69. doi:10.1046/j.1537-2995.1981.21181127486.x.
  • Pollack W, Ascari WQ, Crispen JF, et al. Studies on Rh prophylaxis. II. Rh immune prophylaxis after transfusion with Rh-positive blood. Transfusion. 1971;11:340–344.
  • Yazer M, Triulzi D, Sperry J, et al. Rate of RhD-alloimmunization after the transfusion of RhD-positive red blood cell containing products among injured patients of childbearing age: single center experience and narrative literature review. Hematology. 2021;26:321–327. doi:10.1080/16078454.2021.1905395.
  • Ji Y, Luo G, Fu Y. Incidence of anti-D alloimmunization in D-negative individuals receiving D-positive red blood cell transfusion: A systematic review and meta-analysis. Vox Sang. 2022;117:633–640. doi:10.1111/vox.13232.
  • Raval JS, Madden KM, Neal MD, et al. Anti-D alloimmunization in Rh(D) negative adults with severe traumatic injury. Transfusion. 2021;61(Suppl 1):S144–S9.
  • Marosszeky S, McDonald S, Sutherland J, et al. Suitability of preadmission blood samples for pretransfusion testing in elective surgery. Transfusion. 1997;37:910–912. doi:10.1046/j.1537-2995.1997.37997454016.x.
  • Boisen ML, Collins RA, Yazer MH, et al. Pretransfusion testing and transfusion of uncrossmatched erythrocytes. Anesthesiology. 2015;122:191–195. doi:10.1097/ALN.0000000000000414.
  • Goodell PP, Uhl L, Mohammed M, et al. Risk of hemolytic transfusion reactions following emergency-release RBC transfusion. Am J Clin Pathol. 2010;134:202–206. doi:10.1309/AJCP9OFJN7FLTXDB.
  • Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313:471–482. doi:10.1001/jama.2015.12.
  • Yazer MH, Delaney M, Doughty H, et al. It is time to reconsider the risks of transfusing RhD negative females of childbearing potential with RhD positive red blood cells in bleeding emergencies. Transfusion. 2019;59:3794–3799. doi:10.1111/trf.15569.
  • Standards for blood banks and transfusion services. 32nd ed. Bethesda, Maryland: AABB, 2020.
  • cited 2022 August 23. https://www.census.gov/data/tables/2019/demo/age-and-sex/2019-age-sex-composition.html.
  • Vaajala M, Kuitunen I, Nyrhi L, et al. Birth rate after major trauma in fertile-aged women: a nationwide population-based cohort study in Finland. Reprod Health. 2022;19:73.
  • Seheult JN, Stram MN, Pearce T, et al. The risk to future pregnancies of transfusing Rh(D)-negative females of childbearing potential with Rh(D)-positive red blood cells during trauma resuscitation is dependent on their age at transfusion. Vox Sang. 2021;116(7):831–840.
  • Yazer MH, Spinella PC, Seheult JN. Risk of future haemolytic disease of the fetus and newborn following the transfusion of Rh(D)-positive blood products to Rh(D)-negative children. Vox Sang. 2022;117:291–292. doi:10.1111/vox.13169.
  • Tamai Y, Ohto H, Takahashi H, et al. Transfusion-Related Alloimmunization to Red blood cell antigens in Japanese pediatric recipients. Transfus Med Rev. 2021;35:29–36. doi:10.1016/j.tmrv.2020.09.001.
  • Evers D, Middelburg RA, de Haas M, et al. Red-blood-cell alloimmunisation in relation to antigens’ exposure and their immunogenicity: a cohort study. Lancet Haematol. 2016;3:e284–e292. doi:10.1016/S2352-3026(16)30019-9.
  • Cardigan R, Latham T, Weaver A, et al. Estimating the risks of prehospital transfusion of D-positive whole blood to trauma patients who are bleeding in England. Vox Sang. 2022;117(5):701–707.
  • McGinity AC, Zhu CS, Greebon L, et al. Prehospital low-titer cold-stored whole blood: philosophy for ubiquitous utilization of O-positive product for emergency use in hemorrhage due to injury. J Trauma Acute Care Surg. 2018;84:S115–S9. doi:10.1097/TA.0000000000001905.
  • Yazer MH, Gorospe J, Cap AP. Mixed feelings about mixed field agglutination: A pathway for managing females of childbearing potential of unknown RhD-type who are transfused RhD-positive and RhD-negative red blood cells during emergency hemorrhage resuscitation. Transfusion. 2021;61(Suppl 1):S326–S32.
  • Ayache S, Herman JH. Prevention of D sensitization after mismatched transfusion of blood components: toward optimal use of RhIG. Transfusion. 2008;48:1990–1999. doi:10.1111/j.1537-2995.2008.01800.x.
  • Yazer MH, Dunbar NM, Delaney M, et al. Survey of the RhD selection and issuing practices for uncrossmatched blood products at pediatric trauma hospitals in the United States: The BEST collaborative study. Transfusion. 2021;61:3328–3334. doi:10.1111/trf.16692.
  • Kolodziej JH, Leonard JC, Josephson CD, et al. Survey to inform trial of low-titer group O whole-blood compared to conventional blood components for children with severe traumatic bleeding. Transfusion. 2021;61(Suppl 1):S43–S8.
  • Uhlich R, Hu P, Yazer M, et al. Perception of risk in massive transfusion as it relates to fetal outcomes: A survey of surgeons and nurses at one American trauma center. Transfusion. 2021;61(Suppl 1):S159–S66.
  • Yu G, Siegler J, Hayes J, et al. Attitudes of American adult women toward accepting RhD-mismatched transfusions in bleeding emergencies. Transfusion. 2022;62(Suppl 1):S211–S7.